Connect with us

Ascend Wellness Holdings

Ascend Wellness closes $235M notes offering to refinance debt

Published

on


Ascend Wellness Holdings Inc. (OTCQX: AAWH) has closed a $235 million private placement of senior secured notes, using the proceeds to refinance existing debt.

The multi-state operator said Thursday it issued the 12.75% notes due in 2029 at 94.75% of face value. Ascend used the net proceeds, plus cash on hand, to prepay $215 million of its outstanding term loan.

The remaining $60 million on Ascend’s term loan will continue at a 9.5% interest rate. CEO John Hartmann on Monday called the refinancing “a significant milestone.”

Marketwatch this week reported that the deal ranks as the fifth-largest debt transaction in the legal cannabis industry to date, according to data from Viridian Capital. Seaport Global Securities LLC acted as lead advisor and sole placement agent for the offering.

The notes are secured by most of Ascend’s assets and can be redeemed after two years at set prices.

The refinancing comes after Ascend reported mixed first-quarter results in May. The company saw gross revenue grow 23.4% year-over-year to $174.2 million, but posted a net loss of $18.2 million. Ascend’s debt stood at $237.6 million at that time.

Ascend has been expanding operations, recently acquiring a new cultivation license in Massachusetts and opening new dispensaries. Ohio, where the company has a presence, is expected to transition to adult-use later this year. The company operates in seven states, focusing on late-stage medical and early-stage adult-use markets.

For 2024, Ascend projected 12-15% revenue growth, with goals to generate $55-65 million in cash from operations.



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Ascend Wellness Holdings

Ascend Wellness report full-year revenue increase despite fourth-quarter slump, but full year revenue grew 8.3%

Published

on



Ascend Wellness Holdings Inc. (CSE: AAWH.U) (OTCQX: AAWH) reported revenue for the fourth quarter that ended on Dec. 31, 2024, fell 3% from the previous year, but the company still posted an 8.3% year-over-year grain for the full year.

Fourth-quarter earnings

Total net revenue declined 4% quarter-over-quarter to $136 million, which was also lower than last year’s revenue of $140 million for the same period. The company also missed the Yahoo Finance average analyst estimate for revenue of $140 million.

The company attributed the decline in retail revenue to the softening of sales in Illinois, Massachusetts, Michigan and New Jersey, driven by a combination of pricing pressure and volume. The decline was partially offset by the contribution of adult-use sales in Ohio that began in the prior quarter and the ramp up of new partner stores in Illinois.

Third-party wholesale revenue totaled $45.6 million, which represented a 5% decrease compared to the prior quarter, attributable to declines in Illinois and New Jersey, partially offset by improvements in Massachusetts.

Ascend reported a net loss of $16.8 million for the quarter, which was an improvement over the third quarter net loss of $28.3 million and last year’s net loss of $19 million. The company said the improvements were primarily due to the absence of certain one-time costs recognized in the third quarter of 2024, the contribution of higher margins and a benefit from certain cost-savings initiatives.

Full-year earnings

For the full year, Ascend reported that net revenue increased 8.3% year-over-year to $561.6 million. Retail revenue increased 0.3% year-over-year to $372.2 million, and wholesale revenue increased 28.5% year-over-year to $189.4 million.

Still, the company reported a net loss of $85 million versus a net loss of $48.2 million for 2023.

“The fourth quarter marked the first full quarter with our new management team in place, and I am pleased with the initial progress we made on our key initiatives – improving profitability, maximizing asset efficiency and driving cash flow generation,” CEO Sam Brill said. “This was achieved through our team’s success in substantially completing our $30 million in annualized cost savings target, ahead of plan, and with this milestone completed we have turned our efforts to driving revenue growth.”

Total general and administrative expenses were $40.8 million in the quarter, or 30.0% of revenue, compared to $46.1 million, or 32.6% of revenue, for the third quarter of 2024. The company attributed the improvement of G&A expenses as a percentage of revenue primarily due to certain cost-savings initiatives, lower headcount in the current quarter, and the absence of certain one-time expenses recognized in the third quarter of 2024.

As of Dec. 31, 2024, cash and cash equivalents were $88.3 million, a sequential increase of $23 million. The company’s net debt was $220.2 million.

“Significant progress has been made in strengthening our balance sheet and improving our margins and profitability. This has resulted in a 450 basis point sequential improvement in Adjusted EBITDA margin and $30.1 million in Free Cash Flow generated in the quarter,” CFO Roman Nemchenko said. “Additionally, we have taken steps to rationalize our inventory levels through more rigorous purchase planning meant to clear the backlog.”



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading

Ascend Wellness Holdings

Innovative Industrial Properties feels pain of tenants not paying rent

Published

on



While Innovative Industrial Properties (NYSE: IIPR) had been managing to stay ahead of nonpaying tenants, the cannabis real estate investment trust (REIT) is now suffering along side the rest of the cannabis industry. The reason? One of its largest portfolio holdings has joined the nonpaying cohort.

And now shareholders are throwing in the towel.

In December, IIP told investors that PharmaCann wasn’t paying rent on six of 11 properties, with the base rent, property management fees and estimated tax and insurance payments owed totaling $4.2 million. IIP noted that even though PharmaCann paid rent on the other five properties, it was technically in default on the whole group because of the nonpayment for the six and could be subject to late penalties and interest.

Worst-case scenario, PharmaCann will be evicted – and considering the company is 17% of IIP’s rental income, it would affect the bottom line.

Trouble was brewing

Even before news of the default – which led to 3 million shares being traded and the price falling from $77 down to $73 – shareholders were worried about the tenants. IIPR’s stock was trading around $135 before the third quarter results were published.

Then in November, Green Market Report wrote about IIP feeling the effects of lowered revenue from troubled properties when it reported its earnings. Revenue slid 1.7%, and the company was using deposit money from some of its tenants for rent payments.

During the third quarter, IIP applied $1.4 million of security deposits for payment of rent on four properties leased to 4Front Ventures Corp., one property to TILT Holdings, and one property lease to Emerald Growth. IIP also terminated its lease with Temescal Wellness of Massachusetts Holdings LLC and regained possession of the property previously occupied by that tenant on Sept. 30, 2024.

PharmaCann was not well

PharmaCann is a privately owned multistate operator, which makes it harder to see any cracks in the company. However, during a third quarter earnings call, publicly traded Cronos Group (Nasdaq: CRON) told its investors that it recognized a C$25.7 million impairment loss driven by impairment charges recorded on its PharmaCann option.

Before that, Cronos reported that for the three and six months that ended June 30, 2024, it recognized C$12.9 million and C$25.7 million of impairment loss on its PharmaCann option. Indeed as early as 2022, Cronos was writing down its investment in PharmaCann – clearly a sign of trouble.

In 2022, PharmaCann got a $30 million capital expenditure financing facility from XS Financial to support its growth initiatives. By 2023, PharmaCann was still using this facility, indicating that it was relying on external financing to fund its operations, which meant it wasn’t making enough money on its own.

In addition, PharmaCann’s union workers in New York secured a 20% wage increase in May 2023, which added to the company’s financial pressures. That state’s adult-use program’s rocky rollout also added stress. Still, IIP made a construction investment of $16 million in PharmaCann in February 2024 for a New York property.

By the end of 2024, PharmaCann had closed its LivWell operation in Michigan, citing trouble in that state’s market. However, it seems it was more that just the Michigan market causing the stress for PharmaCann.

A billion wiped out

When IIP told investors it was having trouble with some of its tenants, the stock tumbled from $130 and is lately selling at $67. Share prices have plunged 36% over the past month. With 28.3 million shares outstanding, IIP has lost a whopping $1.7 billion in valuation in a short amount of time. Analysts from BTIG and Compass Point both downgraded the stock in December to Neutral.

While IIP has managed to find new tenants for some of its properties and to continue rent increases for others, PharmaCann could be harder to offset. IIP is already working through challenges with another problem tenant, Parallel Cannabis, in Florida, while Ascend Wellness, its next biggest portfolio exposure, is also seeing its losses mount. Back in August, Ascend slashed its full-year revenue outlook, citing mounting competition in Illinois, Massachusetts and New Jersey. With the lackluster second-quarter results, the company later that month ousted then-CEO John Hartmann and CFO Mark Cassebaum.

IIP is likely to keep close tabs on Ascend’s health as it has now found itself getting dragged down into the cannabis industry’s woes when before it seemed immune.



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading

Ascend Wellness Holdings

The Daily Hit: November 12, 2024

Published

on


News from: Eaze, New York Cannabis Control Board, Cronos Group, Weedmaps and more.

The Daily Hit is a recap of the top financial news stories for Tuesday, November 12, 2024.

On the Site

Eaze secures $10M to resurrect cannabis operations after foreclosure drama

The company did not specify whether previously announced layoffs and closures would be reversed.

Read more here.

New York cannabis board extends social equity deadline, offers payment plan for ROs

State officials also announced it will deploy a seed-to-sale tracking system to replace manual reporting.

Read more here.

Enveric inks $62M licensing deal for psilocin prodrug

The biotech will concentrate on its “trip-free” compound, especially following recent FDA concerns on psychedelic trial designs.

Read more here.

Earnings:

In Other News

New Jersey

New Jersey’s Cannabis Regulatory Commission announced Monday that it would enforce its statewide ban on certain hemp products following a federal ruling. The law, which took effect on October 12, aims to curb the sale of psychoactive hemp items not derived from naturally occurring chemicals.

Read more here.

Inner State Inc.

Inner State Inc., a women’s health and wellness research and development company, and The Ohio State University initiated a research project to identify psilocybin mushroom genetics, novel extracts and potential bioactivity.

Read more here.



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading
video7 hours ago

Fireworks, marijuana and cash found in Bronx apartment – NBC New York

video8 hours ago

How often are marijuana cases federally prosecuted?

featured15 hours ago

A Brief History of Getting High

featured17 hours ago

Rhode Island Marijuana Regulators Seeking Applications For New Dispensary In State’s Northern Region

featured20 hours ago

Texas Medical Marijuana Industry Wants Lawmakers To Ban Synthetic Delta-8 THC And Restrict Hemp Products To Adults

featured23 hours ago

California Cannabis Operators Warn That New Tax Hike ‘Could Kill This Industry’

featured1 day ago

High Times Greats: Jim Morrison

video1 day ago

New cannabis tax increase is a high concern for California dispensaries, customers

featured1 day ago

A Brief History of High Times (2019)

video1 day ago

Georgia veterans suffering from PTSD push for medical cannabis expansion on Fourth of July

featured2 days ago

A Brief Global History of the War on Cannabis

featured2 days ago

The Evolution of Cannabis in Film

featured2 days ago

High Times Is Home Again

featured2 days ago

Dope As Yola Becomes First Weedtuber to Hit 2 Million Subscribers

video2 days ago

$20M worth of cocaine, marijuana seized in Caribbean Sea: USCG

featured2 days ago

Will Success Spoil Cheech & Chong? Of Course (1980)

featured2 days ago

Prescription-Only Rule Takes Hold Amid Political Ouster

featured2 days ago

Marijuana Use Is Tied To ‘Significantly Higher Sexual Desire And Arousal,’ New Study Shows

featured2 days ago

Flashback Friday: Psychedelic Cacti

featured2 days ago

Trump’s VA Secretary Is ‘Particularly Proud’ Of Psychedelic Research Aimed At Helping Veterans With PTSD

featured2 days ago

Democratic Senate Sponsor Of Marijuana Banking Bill Says Budget Issues And War Have Delayed Cannabis Reform Efforts

video2 days ago

Tifton Police: About 20 pounds of marijuana discovered during traffic stop

featured2 days ago

Czech Republic Bill To Legalize Marijuana Home Cultivation And Allow Psilocybin For Medical Use Heads To President’s Desk

featured2 days ago

Pentagon sued over cannabis questions for military contractors (Newsletter: July 4, 2025)

Trending